Reporting Owner Activity for Prime Movers Lab Fund I LP

Form 3/4/5 issuer positions and transaction evidence for this reporting owner.

Issuer positions

2

Largest position

Vaxxinity, Inc.

Disclosed value

$28.09M

Recent activity

Available

Identity
Location
Jackson, WY
SEC ownership signals
Ownership summary

Disclosed holdings value

$28,092,506

Estimated from parsed Forms 3/4/5 holdings when values are available.

Issuer positions

2

Distinct issuers linked to this reporting owner in parsed SEC filings.

Largest parsed position

Vaxxinity, Inc.

About $27.82M reported in parsed filings.

Latest ownership filing

26 Sep 2023

Most recent owner-level filing date in the parsed SEC record.

Values come from parsed SEC Forms 3/4/5 and should be verified against the source filing.

SEC record
Reporting signature
/s/ Taylor Frankel, Authorized Person on behalf of the General Partner of each Reporting Person
SEC evidence

Follow Filing Activity

Follow Prime Movers Lab Fund I LP and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Reported issuer positions for Prime Movers Lab Fund I LP

VAXX Forms 3/4/5

Vaxxinity, Inc.

Relationship
10%+ Owner
Holdings value
$27,817,357
Past year net change
Change %
Report period
06 Sep 2023
MNTS, MNTSW Forms 3/4/5

Momentus Inc.

Relationship
10%+ Owner
Holdings value
$275,149
Past year net change
Change %
Report period
22 Sep 2023

Insider Transactions Reported by Prime Movers Lab Fund I LP:

Sym Company Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .